Filing metadata

Accession number
0001104659-25-067928
Form type
Form 4
Filer
ArriVent BioPharma, Inc.
CIK
CIK 1868279
Filed
Jul 15, 2025
Reporting period
Jul 11, 2025
Description
Insider transaction

Explore SEC Filings Hub